URA, which is now valued at more than $5bn, is set to integrate Dexcom’s glucose capabilities with the Oura ring.

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

We have worked to find the best capture cards currently on the market, and you can rest assured that we've done our research.

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Medical device maker Dexcom said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion. Ōura, founded in Finland in 2013, makes a smart ...

Wearing a CGM has made living with diabetes much more manageable for ... The tubed pumps are as small as a beeper or phone ...

Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors ... About 23% of Oura members ...

It has teamed up with Dexcom, which makes glucose monitors and associated apps, and the data collected from its devices will ...

The most amazing part of being a teacher is witnessing the look on a child’s face when they understand something they thought ...

Brain-computer interface devices like Synchron’s Stentrode are implanted into the brain and allow patients with impaired ...

Treo is a modular platform that works like SoC architecture with a set of ever-evolving IPs for analog and digital building ...